Bring-in of Nintedanib Esilate Soft Capsule Project
2024-05-07
Gyre Pharmaceuticals, jointly with Jiangsu Wangao Pharmaceutical Co., Ltd, has successfull...
"Focused Growth through Innovation: Shaping the Future" Gyre Pharmaceuticals Co., Ltd (also known as Beijing Continent Pharmaceuticals Co., Ltd) Held its First Post-Listing Conference in Beijing
2024-03-05
"Focused Growth through Innovation: Shaping the Future"
Gyre Pharmaceuticals Co., Ltd (a...
Enrollment of F351 Phase III Clinical Trial Subjects Complete
2023-10-26
Significant progress has been made by Beijing Continent Pharmaceuticals Co. Ltd., regardin...